Prolonged cardiac arrest complicating a massive ST-segment elevation myocardial infarction associated with marijuana
Jose Orsini1, Christa Blaak2, Salil Rajayer2
1Department of Medicine, New York University School of Medicine, Woodhull Medical and Mental Health Center, Brooklyn, NY, USA; jose.orsini@woodhullhc.nychhc.org.
Journal of Community Hospital Internal Medicine Perspectives
|September 10, 2016
Summary
Heavy marijuana use can lead to severe cardiovascular events, including heart attacks and prolonged cardiac arrest. This case highlights the potential life-threatening risks associated with cannabis consumption.
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Recreational substance use is a significant public health concern, with drug overdose deaths rising.
- Marijuana is the most commonly used illicit drug globally, with increasing legalization in the US.
- While generally considered low in acute toxicity, heavy marijuana use is linked to severe health consequences.
Observation:
- The case report details a patient experiencing ST-segment elevation myocardial infarction (STEMI).
- This cardiac event was associated with cannabis use.
- The STEMI resulted in a prolonged period of cardiac arrest.
Findings:
- Cannabis-associated myocardial infarction is a rare but serious adverse event.
- Heavy marijuana usage may pose significant cardiovascular risks beyond typical neurobehavioral and gastrointestinal effects.
- This case underscores the potential for severe cardiovascular toxicity from marijuana.
Implications:
- Healthcare providers should consider marijuana use in patients presenting with acute cardiovascular events.
- Further research is needed to understand the mechanisms linking cannabis to cardiovascular complications.
- Public health strategies may need to address the cardiovascular risks of increasing recreational marijuana use.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...


